Britain's medicines regulator is warning some packages of Nurofen Plus could contain a drug often used to treat psychosis and schizophrenia.
Britain's medicines regulator is warning some packages of Nurofen Plus could contain a drug often used to treat psychosis and schizophrenia.

Sabotage suspected as Nurofen packs are recalled

 

Richard Hall
Saturday 27 August 2011 00:00
Comments

The makers of Nurofen Plus recalled the tablets last night and confirmed sabotage was suspected in packets of the painkillers.

There have been five reported cases of other manufacturers' medicines found in boxes of Nurofen Plus after a safety alert on Thursday.

A spokesman for the manufacturer Reckitt Benckiser said: "Sabotage is suspected and we are working with the police on a formal investigation to find the person or persons responsible." Distribution of Nurofen Plus has been halted for the time being, he said.

Investigators are trying to establish how the packs came to contain strips of a potentially harmful drug. Three packs of Nurofen Plus were found to contain blister packs of the anti-psychotic medicine Seroquel XL 50mg. They were bought in Victoria, Bromley and Beckenham.

Yesterday, two more packets were found; one contained Seroquel XL 50mg tablets and the other contained the Pfizer product Neurontin 100mg capsules.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in